首页 > 最新文献

Dementia and Geriatric Cognitive Disorders最新文献

英文 中文
Deciphering Perspectives: A European survey on clinical decision support tools for dementia and Alzheimer's disease.
IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-25 DOI: 10.1159/000544801
Ini Umoh, Xin Xia, Bengt Winblad, Sandar Aye, Emil Aho, Hanneke F M Rhodius-Meester, Linus Jönsson

Introduction: Technological advancements like digital monitoring tools, disease modifying therapies and artificial intelligence have been shown to improve the clinical management of neurocognitive diseases like Alzheimer's disease (AD). To enhance implementation in daily practice, users' input is essential in the technology development process. This study aimed to determine clinician's perspective of clinical decision support systems (CDSS) in the management of dementia and AD.

Method: A survey was conducted targeting clinicians practicing in the field of dementia across Europe. A sixty-five-item digital questionnaire was administered, and opinions were enquired across the domains of diagnosis, disease modifying therapy and prognosis, including factors that affect tool implementation and utilization.

Results: Eighty-four clinicians (including specialist physicians, psychologists and nurses) responded to this survey, and more than 50% had no knowledge or experience with CDSS. Most of the respondents reported the ability to predict the likelihood of AD as the most important diagnostic function. It was surprising to find the middling responses for the ability to predict amyloid positivity. The majority indicated assessment of treatment eligibility for disease-modifying therapy as vital, and the ability to predict cognitive and functional decline as the most important prognostic functions. Data accuracy and ease of use were noted as most necessary to facilitate CDSS adoption and implementation.

Conclusion: Findings from this study contribute to the future development of CDSS in this field, especially regarding the approval and imminent use of disease modifying therapies, a comprehensive tool that is precise and user friendly would improve clinical decisions and efficiency.

{"title":"Deciphering Perspectives: A European survey on clinical decision support tools for dementia and Alzheimer's disease.","authors":"Ini Umoh, Xin Xia, Bengt Winblad, Sandar Aye, Emil Aho, Hanneke F M Rhodius-Meester, Linus Jönsson","doi":"10.1159/000544801","DOIUrl":"https://doi.org/10.1159/000544801","url":null,"abstract":"<p><strong>Introduction: </strong>Technological advancements like digital monitoring tools, disease modifying therapies and artificial intelligence have been shown to improve the clinical management of neurocognitive diseases like Alzheimer's disease (AD). To enhance implementation in daily practice, users' input is essential in the technology development process. This study aimed to determine clinician's perspective of clinical decision support systems (CDSS) in the management of dementia and AD.</p><p><strong>Method: </strong>A survey was conducted targeting clinicians practicing in the field of dementia across Europe. A sixty-five-item digital questionnaire was administered, and opinions were enquired across the domains of diagnosis, disease modifying therapy and prognosis, including factors that affect tool implementation and utilization.</p><p><strong>Results: </strong>Eighty-four clinicians (including specialist physicians, psychologists and nurses) responded to this survey, and more than 50% had no knowledge or experience with CDSS. Most of the respondents reported the ability to predict the likelihood of AD as the most important diagnostic function. It was surprising to find the middling responses for the ability to predict amyloid positivity. The majority indicated assessment of treatment eligibility for disease-modifying therapy as vital, and the ability to predict cognitive and functional decline as the most important prognostic functions. Data accuracy and ease of use were noted as most necessary to facilitate CDSS adoption and implementation.</p><p><strong>Conclusion: </strong>Findings from this study contribute to the future development of CDSS in this field, especially regarding the approval and imminent use of disease modifying therapies, a comprehensive tool that is precise and user friendly would improve clinical decisions and efficiency.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":" ","pages":"1-17"},"PeriodicalIF":2.2,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143499690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum.
IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-13 DOI: 10.1159/000543461
{"title":"Erratum.","authors":"","doi":"10.1159/000543461","DOIUrl":"https://doi.org/10.1159/000543461","url":null,"abstract":"","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":" ","pages":"1"},"PeriodicalIF":2.2,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143413557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diversity in United States dementia prevention trials: An updated systematic review of eligibility criteria and recruitment strategies.
IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-13 DOI: 10.1159/000543905
Najoua Lazaar, Sabine E Van Beek, Awaale F Rirash, Janne M Papma, Jaime Perales-Puchalt, Ashley R Shaw, Eric D Vidoni, Sanne Franzen

Introduction: Given the elevated dementia risk in underrepresented demographic groups in the US-particularly in Latino and Non-Latino Black individuals compared to Non-Latino White individuals-it is vital that these groups are well-represented in dementia prevention research. Eligibility criteria and recruitment strategies may play a key role in promoting participant diversity. The aim of this review was to examine eligibility criteria and recruitment strategies in US dementia prevention trials in light of participant diversity.

Methods: A systematic review was conducted using Medline (including PubMed), Embase, Cochrane Library and CINAHL. We explored the percent White participants for trials using vs. not using a specific eligibility criterion or recruitment strategy using Hodges-Lehmann median difference estimation.

Results: Of forty-four studies meeting the inclusion criteria, twenty-seven reported on racial/ethnic diversity. Analyses demonstrated that criteria regarding cardiovascular disease, pulmonary disease, hearing impairment, and sedentary lifestyle were associated with relatively high participant diversity, while gastro-intestinal/liver disease, motivation to participate, and language proficiency criteria were associated with relatively little diversity. Information on recruitment strategies was often lacking. Three studies described recruitment efforts explicitly aimed at increasing diversity. Recruitment strategies associated with relatively high racial/ethnic diversity included recruitment via referral/word-of-mouth, television/radio advertising, and recruitment at church.

Conclusion: Eligibility criteria could be improved by revisiting and revising how they are defined (e.g. motivation to participate). Regarding recruitment, several recommendations are provided, including 1) lifting barriers to study participation (e.g. through reimbursement), 2) collaborating with community partners, and 3) formally studying the effectiveness of recruitment strategies.

{"title":"Diversity in United States dementia prevention trials: An updated systematic review of eligibility criteria and recruitment strategies.","authors":"Najoua Lazaar, Sabine E Van Beek, Awaale F Rirash, Janne M Papma, Jaime Perales-Puchalt, Ashley R Shaw, Eric D Vidoni, Sanne Franzen","doi":"10.1159/000543905","DOIUrl":"https://doi.org/10.1159/000543905","url":null,"abstract":"<p><strong>Introduction: </strong>Given the elevated dementia risk in underrepresented demographic groups in the US-particularly in Latino and Non-Latino Black individuals compared to Non-Latino White individuals-it is vital that these groups are well-represented in dementia prevention research. Eligibility criteria and recruitment strategies may play a key role in promoting participant diversity. The aim of this review was to examine eligibility criteria and recruitment strategies in US dementia prevention trials in light of participant diversity.</p><p><strong>Methods: </strong>A systematic review was conducted using Medline (including PubMed), Embase, Cochrane Library and CINAHL. We explored the percent White participants for trials using vs. not using a specific eligibility criterion or recruitment strategy using Hodges-Lehmann median difference estimation.</p><p><strong>Results: </strong>Of forty-four studies meeting the inclusion criteria, twenty-seven reported on racial/ethnic diversity. Analyses demonstrated that criteria regarding cardiovascular disease, pulmonary disease, hearing impairment, and sedentary lifestyle were associated with relatively high participant diversity, while gastro-intestinal/liver disease, motivation to participate, and language proficiency criteria were associated with relatively little diversity. Information on recruitment strategies was often lacking. Three studies described recruitment efforts explicitly aimed at increasing diversity. Recruitment strategies associated with relatively high racial/ethnic diversity included recruitment via referral/word-of-mouth, television/radio advertising, and recruitment at church.</p><p><strong>Conclusion: </strong>Eligibility criteria could be improved by revisiting and revising how they are defined (e.g. motivation to participate). Regarding recruitment, several recommendations are provided, including 1) lifting barriers to study participation (e.g. through reimbursement), 2) collaborating with community partners, and 3) formally studying the effectiveness of recruitment strategies.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":" ","pages":"1-22"},"PeriodicalIF":2.2,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143413556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structural neuroimaging correlates of neuropsychiatric symptoms in Alzheimer's disease: A systematic literature review.
IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-12 DOI: 10.1159/000543160
Meghan K Ramirez, Connor J Phipps, Daniel L Murman, Janelle N Beadle, Vaishali S Phatak, David E Warren

Introduction: Neuropsychiatric symptoms (NPSs) such as increased apathy, affective symptoms, psychosis and hyperactivity are common in Alzheimer's disease (AD) and are associated with increased disease severity and caregiver burden. In contrast to well-characterized associations between AD-related cognitive deficits and focal neuropathology (e.g., memory and hippocampal atrophy), fewer studies have focused on associations between NPS-brain associations in AD. Furthermore, studies focusing on MRI measures of gray matter (GM) abnormalities associated with NPSs in AD have not been systematically reviewed.

Methods: To address this gap, a systematic literature review was undertaken to identify articles that assessed structural brain differences associated with NPSs in AD. This review identified 29 such articles that tested associations between NPSs and gray matter loss (GML: reduced GM density, reduced GM volume, decreased cortical thickness, etc.).

Results: Across all NPSs, most symptoms were associated with GML the prefrontal cortex and medial temporal lobe highlighting key limbic/limbic adjacent structures including orbitofrontal cortex and parahippocampal regions. Other regions exhibiting associations included the superior and middle temporal gyri as well as anterior and posterior cingulate cortex.

Conclusion: Understanding how GM changes in the brain relate to NPSs in AD may not only improve our understanding of NPSs and AD but may also provide help to identify homologies/correspondence with brain changes in psychiatric diseases.

{"title":"Structural neuroimaging correlates of neuropsychiatric symptoms in Alzheimer's disease: A systematic literature review.","authors":"Meghan K Ramirez, Connor J Phipps, Daniel L Murman, Janelle N Beadle, Vaishali S Phatak, David E Warren","doi":"10.1159/000543160","DOIUrl":"https://doi.org/10.1159/000543160","url":null,"abstract":"<p><strong>Introduction: </strong>Neuropsychiatric symptoms (NPSs) such as increased apathy, affective symptoms, psychosis and hyperactivity are common in Alzheimer's disease (AD) and are associated with increased disease severity and caregiver burden. In contrast to well-characterized associations between AD-related cognitive deficits and focal neuropathology (e.g., memory and hippocampal atrophy), fewer studies have focused on associations between NPS-brain associations in AD. Furthermore, studies focusing on MRI measures of gray matter (GM) abnormalities associated with NPSs in AD have not been systematically reviewed.</p><p><strong>Methods: </strong>To address this gap, a systematic literature review was undertaken to identify articles that assessed structural brain differences associated with NPSs in AD. This review identified 29 such articles that tested associations between NPSs and gray matter loss (GML: reduced GM density, reduced GM volume, decreased cortical thickness, etc.).</p><p><strong>Results: </strong>Across all NPSs, most symptoms were associated with GML the prefrontal cortex and medial temporal lobe highlighting key limbic/limbic adjacent structures including orbitofrontal cortex and parahippocampal regions. Other regions exhibiting associations included the superior and middle temporal gyri as well as anterior and posterior cingulate cortex.</p><p><strong>Conclusion: </strong>Understanding how GM changes in the brain relate to NPSs in AD may not only improve our understanding of NPSs and AD but may also provide help to identify homologies/correspondence with brain changes in psychiatric diseases.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":" ","pages":"1-22"},"PeriodicalIF":2.2,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143406125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longitudinal analysis of objective and self-reported cognitive functions in individuals with subjective cognitive decline.
IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-06 DOI: 10.1159/000543230
Seon Young Ryu, Chunghwee Lee, Seong Hee Ho, Yun Jeong Hong, Jee Hyang Jeong, Kee Hyung Park, Min Jeong Wang, Seong Hye Choi, SangYun Kim, Dong Won Yang

Introduction: Subjective cognitive decline (SCD) is considered a preclinical manifestation of Alzheimer's disease (AD). Recent research suggests that subtle cognitive changes in SCD are linked to an increased risk of clinical decline. This study investigates the longitudinal trajectories of both objective and self-reported cognitive functions in individuals with SCD, with a focus on the impact of subtle cognitive impairment (SCI).

Methods: A total of 107 individuals with SCD, with at least two annual follow-ups, were included in this study. We analyzed the trajectories of both objective and subjective cognitive functions, assessed changes in medial temporal lobe regional volumes, and compared baseline AD biomarkers between SCD individuals with SCI (n = 22, SCI group) and without SCI (n = 85).

Results: SCD individuals with SCI showed a faster decline in objective cognitive function over time compared to those without SCI, who exhibited cognitive improvement. Self-reported cognitive complaints showed no differences between groups at baseline or in annual changes over time. The SCI group had lower baseline entorhinal cortical volumes and greater volume reductions over time, and also exhibited more abnormalities in AD biomarkers, including higher amyloid PET positivity, a lower Aβ 42/40 ratio, and elevated p-tau181.

Conclusion: SCI status in SCD individuals is associated with significant cognitive decline, along with more abnormal AD biomarkers. These findings suggest that early identification of SCI status in individuals with SCD may improve the prediction of cognitive decline. However, self-reported cognitive complaints may have a limited role in monitoring clinical changes in SCD.

{"title":"Longitudinal analysis of objective and self-reported cognitive functions in individuals with subjective cognitive decline.","authors":"Seon Young Ryu, Chunghwee Lee, Seong Hee Ho, Yun Jeong Hong, Jee Hyang Jeong, Kee Hyung Park, Min Jeong Wang, Seong Hye Choi, SangYun Kim, Dong Won Yang","doi":"10.1159/000543230","DOIUrl":"https://doi.org/10.1159/000543230","url":null,"abstract":"<p><strong>Introduction: </strong>Subjective cognitive decline (SCD) is considered a preclinical manifestation of Alzheimer's disease (AD). Recent research suggests that subtle cognitive changes in SCD are linked to an increased risk of clinical decline. This study investigates the longitudinal trajectories of both objective and self-reported cognitive functions in individuals with SCD, with a focus on the impact of subtle cognitive impairment (SCI).</p><p><strong>Methods: </strong>A total of 107 individuals with SCD, with at least two annual follow-ups, were included in this study. We analyzed the trajectories of both objective and subjective cognitive functions, assessed changes in medial temporal lobe regional volumes, and compared baseline AD biomarkers between SCD individuals with SCI (n = 22, SCI group) and without SCI (n = 85).</p><p><strong>Results: </strong>SCD individuals with SCI showed a faster decline in objective cognitive function over time compared to those without SCI, who exhibited cognitive improvement. Self-reported cognitive complaints showed no differences between groups at baseline or in annual changes over time. The SCI group had lower baseline entorhinal cortical volumes and greater volume reductions over time, and also exhibited more abnormalities in AD biomarkers, including higher amyloid PET positivity, a lower Aβ 42/40 ratio, and elevated p-tau181.</p><p><strong>Conclusion: </strong>SCI status in SCD individuals is associated with significant cognitive decline, along with more abnormal AD biomarkers. These findings suggest that early identification of SCI status in individuals with SCD may improve the prediction of cognitive decline. However, self-reported cognitive complaints may have a limited role in monitoring clinical changes in SCD.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":" ","pages":"1-17"},"PeriodicalIF":2.2,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Mediating Effect of Depressive Symptoms between Frailty and Cognitive Impairment in the Northeast Chinese Older Adults.
IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-01-30 DOI: 10.1159/000543830
Xiaohan Geng, Changgui Kou, Songyu Wu, Wangyi Zhang, Biao Li, Ge Yu, Yuxuan Shen, Junling Gao, Wenjun Li, Wei Bai

Introduction: Cognitive impairment among older adults is a significant public health concern worldwide. This study aimed to investigate the prevalence of cognitive impairment, its correlates, and the mediating role of depressive symptoms between frailty and cognitive impairment among older adults in northeast region of China.

Methods: This was a cross-sectional study which used the intercept interview method to recruit participants. Social demographic characteristic, health-related behaviours, physical health, and functional status of the participants were collected. Univariate and multivariate analyses were conducted to correlates of cognitive impairment. Additionally, mediating effect analysis was performed using the Bootstrap tool.

Results: Among the 2,859 older adults included in the study, 32.4% of participants screened positive for cognitive impairment. Higher educational attainment had negative association with cognitive impairment in older adults (p < 0.05). Living in rural areas, fair/poor self-rated health, pre-frailty, frailty, having depressive symptoms, impaired activities of daily living, poor sleep quality, and inactive physical activity had positive association with cognitive impairment in older adults (p < 0.05). Furthermore, depressive symptoms exhibited a partial mediating role between frailty and cognitive impairment, with a mediating effect of 58.0%.

Conclusions: Preventive measures should be implemented to address the associated factors with cognitive impairment. Promoting higher education levels, advocating for a positive and healthy lifestyle, and ensuring their physical and mental well-being among older adults are essential. Early diagnosis and proactive prevention of frailty and depressive symptoms in older adults may effectively decelerate cognitive decline.

{"title":"The Mediating Effect of Depressive Symptoms between Frailty and Cognitive Impairment in the Northeast Chinese Older Adults.","authors":"Xiaohan Geng, Changgui Kou, Songyu Wu, Wangyi Zhang, Biao Li, Ge Yu, Yuxuan Shen, Junling Gao, Wenjun Li, Wei Bai","doi":"10.1159/000543830","DOIUrl":"10.1159/000543830","url":null,"abstract":"<p><strong>Introduction: </strong>Cognitive impairment among older adults is a significant public health concern worldwide. This study aimed to investigate the prevalence of cognitive impairment, its correlates, and the mediating role of depressive symptoms between frailty and cognitive impairment among older adults in northeast region of China.</p><p><strong>Methods: </strong>This was a cross-sectional study which used the intercept interview method to recruit participants. Social demographic characteristic, health-related behaviours, physical health, and functional status of the participants were collected. Univariate and multivariate analyses were conducted to correlates of cognitive impairment. Additionally, mediating effect analysis was performed using the Bootstrap tool.</p><p><strong>Results: </strong>Among the 2,859 older adults included in the study, 32.4% of participants screened positive for cognitive impairment. Higher educational attainment had negative association with cognitive impairment in older adults (p < 0.05). Living in rural areas, fair/poor self-rated health, pre-frailty, frailty, having depressive symptoms, impaired activities of daily living, poor sleep quality, and inactive physical activity had positive association with cognitive impairment in older adults (p < 0.05). Furthermore, depressive symptoms exhibited a partial mediating role between frailty and cognitive impairment, with a mediating effect of 58.0%.</p><p><strong>Conclusions: </strong>Preventive measures should be implemented to address the associated factors with cognitive impairment. Promoting higher education levels, advocating for a positive and healthy lifestyle, and ensuring their physical and mental well-being among older adults are essential. Early diagnosis and proactive prevention of frailty and depressive symptoms in older adults may effectively decelerate cognitive decline.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":" ","pages":"1-11"},"PeriodicalIF":2.2,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adaption and Validation of the Greek Version of Addenbrooke's Cognitive Examination III Scale as a Screening Tool for Perioperative Cognitive Impairment Detection. 希腊版Addenbrooke's Cognitive Examination III量表作为围手术期认知功能障碍检测筛查工具的适应和验证。
IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-01-17 DOI: 10.1159/000543441
Georgia Tsaousi, Maria Zouka, Eleni Chatsiou, Anastasia Nikopoulou, Eleftheria Palaska, Vasiliki Birba, Georgios Papazisis, Zoi Tsimtsiou

Introduction: Postoperative cognitive dysfunction constitutes an extremely prevalent implication in individuals subjected to cardiac or noncardiac surgery. This study aimed to assess the validity and reliability of a culturally adapted Greek version of the Addenbrooke's Cognitive Examination III (ACE-III) scale as a screening tool for perioperative neurocognitive status determination in elderly surgical patients.

Methods: A cross-cultural adaptation and validation of instruments throughout the cross-sectional study was conducted. The study sample consisted of 128 individuals over 55 years old scheduled for surgical intervention. All participants were screened twice: at the preadmission clinic and the day before surgery using the already established MoCA scale and the culturally adapted Greek version of the ACE-III scale. Subjects with a MoCA score of <26 constituted the cognitively impaired group.

Results: Regarding construct validity, ACE-III's performance in detecting cognitive impairment was excellent (AUC = 0.942; 95% CI: 0.899-0.971). Convergent validity between ACE-III and MoCA scales was excellent (r = 0.876; 95% CI: 0.839-0.905). Known group validity was confirmed since advanced age and lower educational attainment adversely impacted ACE-III's total score (p < 0.001). Additionally, specialists suggested face validity (mean 8.7 out of 10, SD 1.1). In terms of reliability, ACE-III demonstrated good internal consistency (Cronbach's alpha 0.786) and high inter-rater (intraclass correlation coefficient [ICC] = 0.936 [95% CI: 0.921-0.941]) and test-retest reliability (ICC = 0.972 [95% CI: 0.958-0.981]).

Conclusion: The Greek version of ACE-III is a valid and reliable screening tool that could be routinely employed perioperatively as a valid alternative to the MoCA test to distinguish the mild cognitively impaired from healthy elderly candidates for surgical interventions.

导读:术后认知功能障碍在接受心脏或非心脏手术的个体中极为普遍。本研究旨在评估希腊版本的阿登布鲁克认知检查III (ACE-III)量表作为老年外科患者围手术期神经认知状态测定的筛查工具的有效性和可靠性。方法:在横断面研究中进行了跨文化适应和工具验证。研究样本包括128名55岁以上计划进行手术干预的个体。所有参与者都进行了两次筛查;在入院前诊所和手术前一天使用已经建立的MoCA量表和文化适应的希腊版ACE-III量表。MoCA评分< 26分者为认知障碍组。结果:构效度方面,ACE-III在检测认知障碍方面表现优异(AUC =0.942;95%可信区间0.899 - -0.971)。ACE-III量表与MoCA量表的收敛效度极好(r= 0.876;95%可信区间0.839 - -0.905)。已知的组效度得到了证实,因为年龄较大和受教育程度较低会对ACE-III总分产生不利影响(p结论:希腊版ACE-III是一种有效、可靠的筛查工具,可以在围手术期常规使用,作为MoCA测试的有效替代方案,以区分轻度认知障碍和健康老年人的手术干预候选人。
{"title":"Adaption and Validation of the Greek Version of Addenbrooke's Cognitive Examination III Scale as a Screening Tool for Perioperative Cognitive Impairment Detection.","authors":"Georgia Tsaousi, Maria Zouka, Eleni Chatsiou, Anastasia Nikopoulou, Eleftheria Palaska, Vasiliki Birba, Georgios Papazisis, Zoi Tsimtsiou","doi":"10.1159/000543441","DOIUrl":"10.1159/000543441","url":null,"abstract":"<p><strong>Introduction: </strong>Postoperative cognitive dysfunction constitutes an extremely prevalent implication in individuals subjected to cardiac or noncardiac surgery. This study aimed to assess the validity and reliability of a culturally adapted Greek version of the Addenbrooke's Cognitive Examination III (ACE-III) scale as a screening tool for perioperative neurocognitive status determination in elderly surgical patients.</p><p><strong>Methods: </strong>A cross-cultural adaptation and validation of instruments throughout the cross-sectional study was conducted. The study sample consisted of 128 individuals over 55 years old scheduled for surgical intervention. All participants were screened twice: at the preadmission clinic and the day before surgery using the already established MoCA scale and the culturally adapted Greek version of the ACE-III scale. Subjects with a MoCA score of <26 constituted the cognitively impaired group.</p><p><strong>Results: </strong>Regarding construct validity, ACE-III's performance in detecting cognitive impairment was excellent (AUC = 0.942; 95% CI: 0.899-0.971). Convergent validity between ACE-III and MoCA scales was excellent (r = 0.876; 95% CI: 0.839-0.905). Known group validity was confirmed since advanced age and lower educational attainment adversely impacted ACE-III's total score (p < 0.001). Additionally, specialists suggested face validity (mean 8.7 out of 10, SD 1.1). In terms of reliability, ACE-III demonstrated good internal consistency (Cronbach's alpha 0.786) and high inter-rater (intraclass correlation coefficient [ICC] = 0.936 [95% CI: 0.921-0.941]) and test-retest reliability (ICC = 0.972 [95% CI: 0.958-0.981]).</p><p><strong>Conclusion: </strong>The Greek version of ACE-III is a valid and reliable screening tool that could be routinely employed perioperatively as a valid alternative to the MoCA test to distinguish the mild cognitively impaired from healthy elderly candidates for surgical interventions.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":" ","pages":"1-9"},"PeriodicalIF":2.2,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of an Application-Based Cognitive Screening Test for Older Thai Adults. 基于应用程序的泰国老年人认知筛选测试的验证。
IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-01-02 DOI: 10.1159/000543309
Benjapa Yangyuensathaporn, Supakorn Chansaengpetch, Angkana Jongsawadipatana, Weerasak Muangpaisan

Introduction: The cognitive screening usually requires a face-to-face format, which might limit its use in many circumstances. We aimed to develop a new application-based cognitive screening test (ACST) to serve as an accessible and valid tool in the community.

Methods: The ACST was developed by using paired association and digit span tests. This test was administered to 70 cognitively normal participants, 62 participants with MCI, and 64 participants with dementia. The 2nd edition of the Mini-Mental State Examination (MMSE-2) and the Montreal Cognitive Assessment (MoCA) were collected by certified psychologists. The ACST was self-administered by the participants, with a clinician providing instructions for those with dementia or technological limitations. The diagnosis was made according to DSM-5 criteria by an experienced geriatric neurologist blinded to the application score. Content validity, test-retest reliability, interrater reliability, and correlations between application scores and MMSE-2 and MoCA scores were analyzed.

Results: The sensitivity and specificity for distinguishing cognitively normal participants from non-normal participants were 92.9% and 70%, respectively (cutoff point ≤7). The sensitivity and specificity for distinguishing between the cognitively normal group and the MCI group were 87.1% and 70%, respectively (cut point ≤7). The sensitivity and specificity for distinguishing cognitively normal participants from participants with dementia were 93.8% and 82.9%, respectively (cut point ≤6). A cutoff point ≤6 was considered suitable for participants aged 75 years or older or with 6 or fewer years of education.

Discussion: The ACST is an easy-to-use and valid tool for cognitive screening in older Thai adults in clinical practice. Patients with an application score ≤7 are considered to be at risk of cognitive impairment and to require further evaluation.

认知筛查通常需要面对面的形式,这可能会限制其在许多情况下的使用。我们的目标是开发一种新的基于应用程序的认知筛选测试(ACST),作为社区中可访问和有效的工具。方法采用配对联想测验和数字广度测验编制ACST。这项测试对70名认知正常的参与者、62名轻度认知障碍参与者和64名痴呆症参与者进行了测试。第二版迷你精神状态检查(MMSE-2)和蒙特利尔认知评估(MoCA)由注册心理学家收集。ACST由临床医师进行。诊断是根据DSM-V标准,由一位经验丰富的老年神经学家盲目的应用评分。分析内容效度、重测信度、被测者信度以及应用分数与MMSE-2和MoCA分数的相关性。结果识别认知正常与异常受试者的敏感性和特异性分别为92.9%和70%(截断点≤7),识别认知正常组与MCI组的敏感性和特异性分别为87.1%和70%(截断点≤7),识别认知正常与痴呆患者的敏感性和特异性分别为93.8%和82.9%。分别(截断点≤6)。截断点≤6被认为适用于年龄在75岁及以上或受教育年限在6年及以下的参与者。ACST在临床实践中是一种易于使用和有效的泰国老年人认知筛查工具。应用评分≤7分的患者被认为存在认知障碍风险,需要进一步评估。
{"title":"Validation of an Application-Based Cognitive Screening Test for Older Thai Adults.","authors":"Benjapa Yangyuensathaporn, Supakorn Chansaengpetch, Angkana Jongsawadipatana, Weerasak Muangpaisan","doi":"10.1159/000543309","DOIUrl":"10.1159/000543309","url":null,"abstract":"<p><strong>Introduction: </strong>The cognitive screening usually requires a face-to-face format, which might limit its use in many circumstances. We aimed to develop a new application-based cognitive screening test (ACST) to serve as an accessible and valid tool in the community.</p><p><strong>Methods: </strong>The ACST was developed by using paired association and digit span tests. This test was administered to 70 cognitively normal participants, 62 participants with MCI, and 64 participants with dementia. The 2nd edition of the Mini-Mental State Examination (MMSE-2) and the Montreal Cognitive Assessment (MoCA) were collected by certified psychologists. The ACST was self-administered by the participants, with a clinician providing instructions for those with dementia or technological limitations. The diagnosis was made according to DSM-5 criteria by an experienced geriatric neurologist blinded to the application score. Content validity, test-retest reliability, interrater reliability, and correlations between application scores and MMSE-2 and MoCA scores were analyzed.</p><p><strong>Results: </strong>The sensitivity and specificity for distinguishing cognitively normal participants from non-normal participants were 92.9% and 70%, respectively (cutoff point ≤7). The sensitivity and specificity for distinguishing between the cognitively normal group and the MCI group were 87.1% and 70%, respectively (cut point ≤7). The sensitivity and specificity for distinguishing cognitively normal participants from participants with dementia were 93.8% and 82.9%, respectively (cut point ≤6). A cutoff point ≤6 was considered suitable for participants aged 75 years or older or with 6 or fewer years of education.</p><p><strong>Discussion: </strong>The ACST is an easy-to-use and valid tool for cognitive screening in older Thai adults in clinical practice. Patients with an application score ≤7 are considered to be at risk of cognitive impairment and to require further evaluation.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":" ","pages":"1-12"},"PeriodicalIF":2.2,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142921164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eye-Tracking-Based Cognitive Assessment Efficiently Detects Mild Cognitive Decline in the Predementia Stage. 基于眼动追踪的认知评估可有效检测痴呆前期的轻度认知功能衰退。
IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-04 DOI: 10.1159/000541235
Mizuki Katsuhisa, Akane Oyama, Yuki Ito, Nanami Sugihara, Shin Teshirogi, Sho Yamamoto, Yuya Ikegawa, Tsuneo Nakajima, Yoshitaka Nakatani, Eriko Yamamoto, Hiromi Bando, Sayaka Tanaka, Mamoru Hashimoto, Kazuhiko Iwata, Shuko Takeda

Introduction: The early detection of cognitive decline is key to maximizing the benefits of preventive and therapeutic interventions against dementia. Generally, dementia is first assessed by interview-based neuropsychological tests, but the lengthy interview and mental stress during the assessment process make screenings inefficient. We previously developed a rapid screening test for dementia using an eye-tracking technology (eye-tracking-based cognitive assessment [ETCA]) and reported its utility for clinically detecting cognitive impairment in dementia cases. However, the ETCA's performance in detecting people with mild cognitive decline, which is the major target population for dementia prevention strategies, remains insufficiently examined. Therefore, this study aimed to evaluate the ETCA's performance in individuals aged 40 years and older (n = 94, mean age: 61.0 [SD 13.1] years) without being formally diagnosed with dementia.

Methods: All participants underwent both the ETCA and neuropsychological tests, including the Mini-Mental State Examination (MMSE), Rivermead Behavioral Memory Test (RBMT), and Addenbrooke's Cognitive Examination-III (ACE-III) on the same day. We examined the correlations in scores between the ETCA and each neuropsychological test. Furthermore, we selected participants who earned normal scores in each neuropsychological test and evaluated the ETCA's performance in this subgroup.

Results: Participants' ETCA scores correlated significantly with their scores on neuropsychological tests, including the MMSE, RBMT, and ACE-III. Notably, the ETCA scores correlated with the RBMT or ACE-III scores in individuals who showed normal scores in each neuropsychological test.

Conclusion: The ETCA has the potential to screen mild cognitive decline efficiently at the predementia stage in nonclinical settings.

简介早期发现认知功能衰退是最大限度地发挥痴呆症预防和治疗干预作用的关键。一般情况下,痴呆症首先要通过基于访谈的神经心理测试进行评估,但冗长的访谈和评估过程中的精神压力使得筛查效率低下。此前,我们利用眼动追踪技术开发了一种痴呆症快速筛查测试(基于眼动追踪的认知评估,ETCA),并报道了其在临床检测痴呆症病例认知障碍方面的实用性。然而,ETCA 在检测轻度认知功能减退者(痴呆症预防策略的主要目标人群)方面的性能仍未得到充分研究。因此,本研究旨在评估 ETCA 在 40 岁及以上(n = 94,平均年龄 61.0 [SD 13.1]岁)未被正式诊断为痴呆症患者中的表现:所有参与者都在同一天接受了 ETCA 和神经心理学测试,包括小型精神状态检查 (MMSE)、Rivermead 行为记忆测试 (RBMT) 和 Addenbrooke 认知测试-III (ACE-III)。我们研究了 ETCA 与各项神经心理学测试之间的相关性。此外,我们还挑选了在各项神经心理学测试中获得正常分数的参与者,并评估了 ETCA 在这一分组中的表现:结果:参试者的 ETCA 分数与他们在神经心理学测试(包括 MMSE、RBMT 和 ACE-III)中的分数有显著相关性。值得注意的是,在各项神经心理测试中得分正常的人,其 ETCA 分数与 RBMT 或 ACE-III 分数相关:结论:ETCA 具有在非临床环境中有效筛查痴呆前期轻度认知功能衰退的潜力。
{"title":"Eye-Tracking-Based Cognitive Assessment Efficiently Detects Mild Cognitive Decline in the Predementia Stage.","authors":"Mizuki Katsuhisa, Akane Oyama, Yuki Ito, Nanami Sugihara, Shin Teshirogi, Sho Yamamoto, Yuya Ikegawa, Tsuneo Nakajima, Yoshitaka Nakatani, Eriko Yamamoto, Hiromi Bando, Sayaka Tanaka, Mamoru Hashimoto, Kazuhiko Iwata, Shuko Takeda","doi":"10.1159/000541235","DOIUrl":"10.1159/000541235","url":null,"abstract":"<p><strong>Introduction: </strong>The early detection of cognitive decline is key to maximizing the benefits of preventive and therapeutic interventions against dementia. Generally, dementia is first assessed by interview-based neuropsychological tests, but the lengthy interview and mental stress during the assessment process make screenings inefficient. We previously developed a rapid screening test for dementia using an eye-tracking technology (eye-tracking-based cognitive assessment [ETCA]) and reported its utility for clinically detecting cognitive impairment in dementia cases. However, the ETCA's performance in detecting people with mild cognitive decline, which is the major target population for dementia prevention strategies, remains insufficiently examined. Therefore, this study aimed to evaluate the ETCA's performance in individuals aged 40 years and older (n = 94, mean age: 61.0 [SD 13.1] years) without being formally diagnosed with dementia.</p><p><strong>Methods: </strong>All participants underwent both the ETCA and neuropsychological tests, including the Mini-Mental State Examination (MMSE), Rivermead Behavioral Memory Test (RBMT), and Addenbrooke's Cognitive Examination-III (ACE-III) on the same day. We examined the correlations in scores between the ETCA and each neuropsychological test. Furthermore, we selected participants who earned normal scores in each neuropsychological test and evaluated the ETCA's performance in this subgroup.</p><p><strong>Results: </strong>Participants' ETCA scores correlated significantly with their scores on neuropsychological tests, including the MMSE, RBMT, and ACE-III. Notably, the ETCA scores correlated with the RBMT or ACE-III scores in individuals who showed normal scores in each neuropsychological test.</p><p><strong>Conclusion: </strong>The ETCA has the potential to screen mild cognitive decline efficiently at the predementia stage in nonclinical settings.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":" ","pages":"29-39"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship between Mentally Active Sedentary Behavior and Cognitive Function across Different Educational Levels. 不同教育水平下的精神活跃久坐行为与认知功能之间的关系。
IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-01-01 Epub Date: 2024-07-22 DOI: 10.1159/000539863
Julinling Hu, Qian Deng, Chan Yong, Jie Peng, Chuiran Kong, Nanyan Li, Xianlan Li, Qin Ye, Qianqian Liu, Yufei Wang, Junmin Zhou

Introduction: How education affects the relationship between sedentary behavior and cognitive function remains unclear. The aim of this study was to investigate the relationship between mentally active sedentary behavior and cognitive function in rural older Chinese across different levels of education.

Methods: Data from 517 participants aged 60 years and older in rural China at baseline, 4 weeks, 8 weeks, 6 months, 12 months, and 24 months were analyzed. Univariate analysis was carried out using descriptive statistical techniques and bivariate analysis was performed using linear mixed effects models.

Results: Total mentally active sedentary behavior time and playing cards/mahjong time were significantly associated with global cognition (0.25 points [95% CI, 0.15-0.35], p < 0.001; 0.27 points [95% CI, 0.16-0.37], p < 0.001, respectively), the attention dimension (0.07 points [95% CI, 0.01-0.12], p = 0.025; 0.08 points [95% CI, 0.02-0.14], p = 0.011, respectively), and the memory dimension (0.20 points [95% CI, 0.13-0.26], p < 0.001; 0.18 points [95% CI, 0.12-0.25], p < 0.001, respectively). Such associations were more pronounced in illiterate participants.

Conclusion: Our study suggested a positive association between mentally active sedentary behavior and cognitive function, with the association being more pronounced among illiterate older adults compared to the relatively well-educated. Future cognitive interventions should focus more on mentally active behavior. In addition, education-specific intervention strategy may be considered in cognitive interventions.

引言教育程度如何影响久坐行为与认知功能之间的关系尚不清楚。本研究旨在调查不同教育水平的中国农村老年人的精神活动性久坐行为与认知功能之间的关系:分析了中国农村地区 517 名 60 岁及以上参与者在基线、4 周、8 周、6 个月、12 个月和 24 个月的数据。使用描述性统计技术进行单变量分析,使用线性混合效应模型进行双变量分析:结果:总的精神活动久坐行为时间和打牌/打麻将时间与总体认知(分别为 0.27 点(95% CI,0.15 至 0.39),P<0.001;0.30 点(95% CI,0.18 至 0.41),P<0.001)、注意力维度(0.分别为 0.08 分(95% CI,0.02 至 0.14),P = 0.005;0.10 分(95% CI,0.04 至 0.16),P = 0.001);记忆维度(分别为 0.18 分(95% CI,0.05 至 0.31),P < 0.001;0.19 分(95% CI,0.13 至 0.25),P<0.001)。这种关联在文盲参与者中更为明显:我们的研究表明,精神活跃的久坐行为与认知功能之间存在正相关,与受教育程度相对较高的老年人相比,文盲老年人的相关性更为明显。未来的认知干预措施应更多地关注精神活跃行为。此外,在进行认知干预时,可考虑采取针对特定教育的干预策略。
{"title":"The Relationship between Mentally Active Sedentary Behavior and Cognitive Function across Different Educational Levels.","authors":"Julinling Hu, Qian Deng, Chan Yong, Jie Peng, Chuiran Kong, Nanyan Li, Xianlan Li, Qin Ye, Qianqian Liu, Yufei Wang, Junmin Zhou","doi":"10.1159/000539863","DOIUrl":"10.1159/000539863","url":null,"abstract":"<p><strong>Introduction: </strong>How education affects the relationship between sedentary behavior and cognitive function remains unclear. The aim of this study was to investigate the relationship between mentally active sedentary behavior and cognitive function in rural older Chinese across different levels of education.</p><p><strong>Methods: </strong>Data from 517 participants aged 60 years and older in rural China at baseline, 4 weeks, 8 weeks, 6 months, 12 months, and 24 months were analyzed. Univariate analysis was carried out using descriptive statistical techniques and bivariate analysis was performed using linear mixed effects models.</p><p><strong>Results: </strong>Total mentally active sedentary behavior time and playing cards/mahjong time were significantly associated with global cognition (0.25 points [95% CI, 0.15-0.35], p < 0.001; 0.27 points [95% CI, 0.16-0.37], p < 0.001, respectively), the attention dimension (0.07 points [95% CI, 0.01-0.12], p = 0.025; 0.08 points [95% CI, 0.02-0.14], p = 0.011, respectively), and the memory dimension (0.20 points [95% CI, 0.13-0.26], p < 0.001; 0.18 points [95% CI, 0.12-0.25], p < 0.001, respectively). Such associations were more pronounced in illiterate participants.</p><p><strong>Conclusion: </strong>Our study suggested a positive association between mentally active sedentary behavior and cognitive function, with the association being more pronounced among illiterate older adults compared to the relatively well-educated. Future cognitive interventions should focus more on mentally active behavior. In addition, education-specific intervention strategy may be considered in cognitive interventions.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":" ","pages":"1-9"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141533943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Dementia and Geriatric Cognitive Disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1